Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Prof-001
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II/ Phase III
Recipient : ProFem GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Prof-001 is a drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Candidiasis, Vulvovaginal.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
February 02, 2021
Lead Product(s) : Prof-001
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Recipient : ProFem GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable